Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel E Bauer

Showing results (11-20 of 133) with videos related to

Pageof 14
Sort By:
Annual Review of Medicine|October 26, 2018
Emerging Genetic Therapy for Sickle Cell DiseaseStuart H Orkin, Daniel E Bauer
Current Opinion in Pediatrics|December 16, 2010
Update on fetal hemoglobin gene regulation in hemoglobinopathiesDaniel E Bauer, Stuart H Orkin
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 10, 2021
Editing outside the body: Ex vivo gene-modification for β-hemoglobinopathy cellular therapyTolulope O Rosanwo, Daniel E Bauer
Seminars in Hematology|July 1, 2018
Genetic therapies for sickle cell diseaseErica B Esrick, Daniel E Bauer
Current Opinion in Genetics & Development|September 17, 2015
Hemoglobin switching's surprise: the versatile transcription factor BCL11A is a master repressor of fetal hemoglobinDaniel E Bauer, Stuart H Orkin
Hematology/Oncology Clinics of North America|September 13, 2017
Gene TherapyDaniel E Bauer, Donald B Kohn
Methods in Molecular Biology (Clifton, N.J.)|October 28, 2017
Growing and Genetically Manipulating Human Umbilical Cord Blood-Derived Erythroid Progenitor (HUDEP) Cell LinesDivya S Vinjamur, Daniel E Bauer
The New England Journal of Medicine|March 25, 2026
Genetic Medicine - Primed and ReadyDaniel E Bauer, Stuart H Orkin
Genome Medicine|March 11, 2021
Editing GWAS: experimental approaches to dissect and exploit disease-associated genetic variationShuquan Rao, Yao Yao, Daniel E Bauer
Nature Communications|January 13, 2023
Assessing and advancing the safety of CRISPR-Cas tools: from DNA to RNA editingJianli Tao, Daniel E Bauer, Roberto Chiarle
Pageof 14

Showing results (11-20 of 133) with videos related to

Sort By:
Pageof 14
Annual Review of Medicine|October 26, 2018
Emerging Genetic Therapy for Sickle Cell DiseaseStuart H Orkin, Daniel E Bauer
Current Opinion in Pediatrics|December 16, 2010
Update on fetal hemoglobin gene regulation in hemoglobinopathiesDaniel E Bauer, Stuart H Orkin
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 10, 2021
Editing outside the body: Ex vivo gene-modification for β-hemoglobinopathy cellular therapyTolulope O Rosanwo, Daniel E Bauer
Seminars in Hematology|July 1, 2018
Genetic therapies for sickle cell diseaseErica B Esrick, Daniel E Bauer
Current Opinion in Genetics & Development|September 17, 2015
Hemoglobin switching's surprise: the versatile transcription factor BCL11A is a master repressor of fetal hemoglobinDaniel E Bauer, Stuart H Orkin
Hematology/Oncology Clinics of North America|September 13, 2017
Gene TherapyDaniel E Bauer, Donald B Kohn
Methods in Molecular Biology (Clifton, N.J.)|October 28, 2017
Growing and Genetically Manipulating Human Umbilical Cord Blood-Derived Erythroid Progenitor (HUDEP) Cell LinesDivya S Vinjamur, Daniel E Bauer
The New England Journal of Medicine|March 25, 2026
Genetic Medicine - Primed and ReadyDaniel E Bauer, Stuart H Orkin
Genome Medicine|March 11, 2021
Editing GWAS: experimental approaches to dissect and exploit disease-associated genetic variationShuquan Rao, Yao Yao, Daniel E Bauer
Nature Communications|January 13, 2023
Assessing and advancing the safety of CRISPR-Cas tools: from DNA to RNA editingJianli Tao, Daniel E Bauer, Roberto Chiarle
Pageof 14